Showing 1 - 4 results of 4 for search 'Maud Beillat', query time: 0.03s Refine Results
  1. 1
    Modeling the public health impact of voxelotor in the management of sickle cell disease in France.

    Modeling the public health impact of voxelotor in the management of sickle cell disease in France. by Frédéric Galacteros, Olivier Ethgen, Maud Beillat

    Published 2023-01-01
    Get full text
    Article
  2. 2
    Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires

    Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires by Maud Beillat, Isabelle Durand-Zaleski, France Pirenne, Stève Bénard, Louis Chillotti, Frédéric Galacteros

    Published 2023-09-01
    Get full text
    Article
  3. 3
    Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

    Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis by Christophe Sapin, Ann Hartry, Siddhesh A Kamat, Maud Beillat, Ross A Baker, Anna Eramo

    Published 2016-09-01
    Get full text
    Article
  4. 4
    Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam

    Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam by Hai-Yen Nguyen-Thi, Nga TQ. Nguyen, Nga TQ. Nguyen, Nguyen Dang Tu Le, Maud Beillat, Olivier Ethgen, Olivier Ethgen

    Published 2020-10-01
    Get full text
    Article

Search Tools: